https://it.marketscreener.com/quotazioni/azione/SYNAPTOGENIX-INC-120797989/attualita/Synaptogenix-Inc-e-Cleveland-Clinic-presenteranno-alla-FDA-la-domanda-di-sperimentazione-di-un-nuo-44370277/?utm_source=telegram&utm_medium=social&utm_campaign=share